NL-OMON33239已完成不适用
Human cell-sources for heart valve tissue engineering. - The HVTE Cell-source study
niversitair Medisch Centrum Utrecht0 个研究点目标入组 10 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Patients that must undergo on pump coronary artery bypass-grafting including a venous graft.
排除标准
- 未提供
研究者
相似试验
招募中
不适用
Conversion of human atrial or dermal fibroblasts into iPS cells or cardiomyocytes using a direct reprogramming strategy.Mase operationJPRN-UMIN000016798Department of cardiology International medical center Saitama Medical University100
招募中
不适用
Development of tissue-engineering mesothelial cell sheets by using human peritoneumGynecologic benign diseaseJPRN-UMIN000017058Juntendo University Faculty of Medicine100
已完成
1 期
Transplantation of Human Embryonic Stem Cell-derived Progenitors in Severe Heart FailureIschemic Heart DiseaseNCT02057900Assistance Publique - Hôpitaux de Paris10
招募中
不适用
Molecular and Cellular Characterization of Cardiac Tissue in Postnatal DevelopmentTetralogy of FallotCongenital Heart DiseaseNCT00243776Emory University600
已完成
1 期
Hybrid biotherapy involving autologous human cardiac stem cell transplantation combined with the controlled release of bFGF using a gelatin hydrogel sheet to treat severe refractory heart failure with chronic ischemic cardiomyopathysevere refractory heart failure with chronic ischemic cardiomyopathyJPRN-UMIN000002518Kyoto Prefectural University School of Medicine6